AliveCor KardiaMobile 6L

Description

»KardiaMobile 6L« device is the first and only six-lead personal ECG that detects more arrhythmias than any other personal ECG device. »KardiaMobile 6L« is the world’s most clinically-validated personal ECG solution and provides instant detection of atrial fibrillation, the most common arrhythmia and one associated with a highly elevated risk of stroke, and other arrhythmias. It is the first AI-enabled platform cleared by the U.S. FDA to aid in the early detection of atrial fibrillation.

Statement of the jury

The platform and AI-supported six-channel EKG »KardiaMobile 6L« from AliveCor helps affected patients to recognize atrial arrhythmia immediately and thus at an early stage.